SAM-e 400 mg Ingredients & Drug Interactions
What is this page for?
First and foremost: checking SAM-e 400 mg against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
SAM-e 400 mg is a dietary supplement by aSquared Nutrition with 1 active ingredient. Its ingredients are commonly taken for depression, osteoarthritis joint pain, liver conditions.Based on those ingredients, 189 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are SAM-e. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against SAM-e 400 mg by aSquared Nutrition
Ask about any prescription or over-the-counter medication and we check it for interactions with SAM-e 400 mg by aSquared Nutrition — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of SAM-e 400 mg by aSquared Nutrition
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
This product contains one active ingredient: SAM-e (S-adenosylmethionine), a compound your body naturally makes that plays a role in mood regulation, joint health, and liver function. The capsule also holds vegetable cellulose and rice flour as inactive ingredients.
Does it work?
Strong evidence
SAM-e is likely effective for osteoarthritis. It's possibly effective for depression and for cholestasis (a liver condition involving reduced bile flow).
For Alzheimer disease and ADHD, the evidence isn't established enough in our data to rate it.
How safe is it?
Well-documented data
SAM-e is generally well tolerated in typical doses, though it can cause stomach upset—nausea, diarrhea, constipation, and indigestion are the most common side effects, especially at higher doses. The facts also note it may trigger mania in people with bipolar disorder, so caution is needed if that applies to you.
Safety data overall isn't well established, so this should be used only under the guidance of your doctor or pharmacist.
Meds to double-check
Moderate interaction found
Before taking this product, check with your doctor or pharmacist if you take any serotonergic drugs—including SSRIs, SNRIs, tricyclic antidepressants, or anti-anxiety medications—or if you take levodopa for Parkinson disease. Both carry moderate-severity interaction risks.
The bottom line
Scorecard at a glanceFully disclosed formula with strong clinical evidence behind its ingredients' uses. Moderate medication interactions have been identified, and safety information is well characterized.
SAM-e may help with osteoarthritis and possibly with depression, but it's a supplement that works on your brain chemistry and carries real interaction risks. If you take any serotonergic antidepressant, anti-anxiety medication, or levodopa for Parkinson disease, or if you have bipolar disorder, talk it over with your doctor or pharmacist before starting it.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated May 19, 2022.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about SAM-e 400 mg, straight from the product label.
| Brand | aSquared Nutrition |
|---|---|
| Barcode (UPC) | X001G94HRH |
| Net contents | 90 Capsule(s) |
| Market status | On market |
| Date entered into DSLD | May 19, 2022 |
| DSLD ID | 264047 |
| Product type | Non-nutrient/non-botanical |
| Supplement form | Capsule |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Vegan, Vegetarian, Adult (18 - 50 Years), Women (not pregnant or lactating) |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for SAM-e 400 mg by aSquared Nutrition, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| SAM-e | 400 mg | -- |
Other ingredients: Vegetable Cellulose, Rice Flour
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Suggested/Recommended/Usage/Directions
Suggested Use: For adults, take one (1) capsule once or twice daily before a meal, or as directed by your physician. Do not take more than two (2) capsules per day.
Precautions
Caution: Do not exceed the recommended dose.
Not intended for pregnant or nursing mothers.
Not intended for children under 18 years of age.
If you are taking any medications (especially antidepressants), have a known medical condition, or are planning a medical procedure, consult your doctor before use.
Discontinue use and consult your doctor if any adverse reactions occur. Individuals with bipolar disorder and manic depression should avoid this supplement.
Keep out of reach of children.
Do not use if safety seal is damaged or missing.
Storage
Store in a cool, dry place.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Formulation
Vegan friendly
Maximum strength Supports well-being & healthy mood Promotes healthy brain function Supports joint & liver health
No preservatives
General Statements
90 capsules
Please recycle.
FDA Statement of Identity
Dietary Supplement
Seals/Symbols
USA Formulated
GMP Good Manufacturing Practice Quality Assured
Formula
aSquared Nutrition is proud to offer a maximum strength SAM-e supplement. Our potent formula contains 400 mg of SAM-e in each capsule, with 90 capsules in each bottle. SAM-e supports well-being & healthy mood, promotes healthy brain function, and supports joint and liver health.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
SAM-e 400 mg by aSquared Nutrition label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in SAM-e 400 mg by aSquared Nutrition
This is the 1 active ingredient this product is made of. Select it to open its full monograph.
Serving size1 Vegetable Capsule(s) Dosage formCapsule Servings per container90 Amounts shown are per serving.
SAM-e
Interacts with189 drugs
SAM-e is a compound your body makes naturally that is sold as a supplement, most often for depression and osteoarthritis. Some research suggests it ma...
SAM-e monograph & interactionsOther (inactive) ingredients: Vegetable Cellulose, Rice Flour. These complete the product’s ingredient list but are not active constituents.
SAM-e 400 mg by aSquared Nutrition Drug Interactions
HelloPharmacist Interaction Report
SAM-e by aSquared Nutrition interacts with serotonergic drugs (like SSRIs, SNRIs, and others used for depression and anxiety) and with levodopa, a medication for Parkinson disease.
The most serious interaction is with serotonergic drugs: combining SAM-e with them carries a moderate risk of serotonin syndrome, a potentially dangerous condition marked by agitation, confusion, rapid heart rate, and muscle rigidity. SAM-e has its own serotonergic activity, so adding it to these medications could push that effect over the line.
Read the full breakdown — every affected drug type, severity by severity
SAM-e also interacts moderately with levodopa by changing how your body processes it, which may make the medication less effective at controlling Parkinson symptoms. Altogether, these interactions span 189 individual medications.
If you take any serotonergic antidepressant, anti-anxiety drug, or levodopa, check your exact medication list with the search tool on this page or with your doctor or pharmacist before starting SAM-e.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against SAM-e 400 mg?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in SAM-e 400 mg interact with 189 drugs. Click any drug to see the details.
1 of the 1 ingredient in SAM-e 400 mg interact with drugs. Each result below shows which ingredient is responsible. SAM-e
VilazodoneViibryd
How Vilazodone interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Vilazodone interactionVortioxetineBrintellix, Sehippy, Trintellix
How Vortioxetine interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Vortioxetine interactionZiprasidoneGeodon
How Ziprasidone interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Ziprasidone interactionZolmitriptanZomig
How Zolmitriptan interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Zolmitriptan interactionZuclopenthizolClopixol
How Zuclopenthizol interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Zuclopenthizol interactionHydrocortisone, Pyrilamine, ChlorpheniramineHC Derma-Pax Liquid
How Hydrocortisone, Pyrilamine, Chlorpheniramine interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Hydrocortisone, Pyrilamine, Chlorpheniramine interactionMethylphenidate Transdermal SystemDaytrana
How Methylphenidate Transdermal System interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Methylphenidate Transdermal System interactionNefazodoneSerzone
How Nefazodone interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Nefazodone interactionPyrilamine, ChlorpheniramineDerma-Pax
How Pyrilamine, Chlorpheniramine interacts with SAM-e 400 mg — through 1 ingredient. Tap an ingredient for the detail:
Sam-eSerotonergic Drugs Moderate
Interaction Summary
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
Read the full Sam-e + Pyrilamine, Chlorpheniramine interactionEach ingredient & the kinds of drugs it affects
For each ingredient in SAM-e 400 mg with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
SAM-e
Levodopa
SAMe might reduce the effectiveness of levodopa.
SAMe methylates levodopa, which might reduce its effectiveness for treating Parkinson disease.
Serotonergic Drugs
Taking SAMe with serotonergic drugs might increase the risk of serotonin syndrome and other serotonergic side effects.
SAMe has serotonergic effects. Theoretically, combining serotonergic drugs with SAMe might increase the risk of serotonergic side effects, including serotonin syndrome and cerebral vasoconstrictive disorders. In one case report, SAMe 100 mg intramuscularly was given daily with clomipramine (Anafranil) 25 mg per day. When the clomipramine dose was increased to 75 mg per day the patient experienced serotonin syndrome about 48-72 hours later, requiring hospitalization.
Brand information
Manufacturer and brand details for SAM-e 400 mg, from the product label.
aSquared Nutrition
See all aSquared Nutrition products- Name
- aSquared Brands LLC
- Street Address
- 382 NE 191st Street, #98406
- City
- Miami
- State
- Florida
- ZipCode
- 33179
- Phone Number
- Office: 1-800-557-4120
SAM-e 400 mg by aSquared Nutrition: Common Questions
Does SAM-e 400 mg by aSquared Nutrition interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
What's SAM-e and what's it supposed to do?
What side effects might I get?
Is it safe during pregnancy?
Can I take it if I'm breastfeeding?
Does it work for depression?
What's in the capsule besides SAM-e?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if SAM-e 400 mg is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind SAM-e 400 mg’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sources & How We Checked
SAM-e 400 mg's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 31 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Same 31 references
- Perna AF, Castaldo P, Ingrosso D, et al. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin. J Nephrol 1999;12:230-40.
- Mato JM, Camara J, Fernandez de Paz J, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999;30:1081-9. PubMed
- Iruela LM, Minguez L, Merino J, Monedero G. Toxic interaction of S-adenosylmethionine and clomipramine. Am J Psychiatry 1993;150:522. PubMed
- Bradley JD, Flusser D, Katz BP, et al. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis. J Rheumatol 1994;21:905-11.
- Berlanga C, Ortega-Soto HA, Ontiveros M, Senties H. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine. Psychiatry Res 1992;44:257-62. PubMed
- Kagan BL, Sultzer DL, Rosenlicht N, Gerner RH. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 1990;147:591-5. PubMed
- Rosenbaum JF, Fava M, Falk WE, et al. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand 1990;81:432-6. PubMed
- Domljan Z, Vrhovac B, Durrigl T, Pucar I. A double-blind trial of ademetionine vs naproxen in activated gonarthrosis. Int J Clin Pharmacol Ther Toxicol 1989;27:329-33.
- Konig B. A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. Am J Med 1987;83:89-94. PubMed
- Lipinski JF, Cohen BM, Frankenburg F, et al. Open trial of S-adenosylmethionine for treatment of depression. Am J Psychiatry 1984;141:448-50.
- Almasio P, Bortolini M, Pagliaro L, Coltorti M. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis. Drugs 1990;40:111-23. PubMed
- Friedel HA, Goa KL, Benfield P. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 1989;38:389-416. PubMed
- Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994;48:137-52. PubMed
- Frezza M, Centini G, Cammareri G, et al. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology 1990;37:122-5.
- Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002;58:130-3. PubMed
- Charlton CG, Crowell B Jr. Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa. Pharmacol Biochem Behav 1992;43:423-31..
- Goren JL, Stoll AL, Damico KE, et al. Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans. Pharmacotherapy 2004;24:1501-7. PubMed
- Arnold O, Saletu B, Anderer P, et al. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry. Eur Neuropsychopharmacol 2005; PubMed
- Nelson JC. S-adenosyl methionine (SAMe) augmentation in major depressive disorder. (Editorial). Am J Psychiatry 2010;167:889-91.
- Kim J, Lee EY, Koh EM, et al. Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients. Clin Ther 2009; PubMed
- Manzillo G, Piccinino F, Surrenti C, et al. Multicentre double-blind placebo-controlled study of intravenous and oral S-adenosyl-L-methionine (SAMe) in cholestatic patients with liver disease. Drug Invest 1992;4 (Suppl 4):90-100. DOI
- Carrieri PB, Indaco A, Gentile S, et al. S-adenosylmethionine treatment of depressioin in patients with Parkinson's disease: a double-blind, crossover study versus placebo. Curr Ther Res 1990;48(1):154-60.
- Pancheri P, Scapicchio P, Delle Chiaie R. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder. Int J Neuro PubMed
- Medici V., Virata M. C., Peerson J. M., Stabler S. P., French S. W., Gregory J. F. III, Albanese A., Bowlus C. L., Devaraj S., Panacek E. A., Richards J. R., Halsted C. H. S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, ra
- Chitiva, H., Audivert, F., and Alvarez, C. Suicide attempt by self-burning associated with ingestion of S-adenosylmethionine: a review of the literature and case report. J.Nerv.Ment.Dis. 2012;200(1):99-101. PubMed
- Carney, M. W., Edeh, J., Bottiglieri, T., Reynolds, E. M., and Toone, B. K. Affective illness and S-adenosyl methionine: a preliminary report. Clin Neuropharmacol. 1986;9(4):379-385. PubMed
- Miccoli, L., Porro, V., and Bertolino, A. Comparison between the antidepressant activity and of S- adenosylmethionine (SAMe) and that of some tricyclic drugs. Acta Neurol (Napoli) 1978;33 (3):243-255.
- Bacci, Ballerini F., Lopez, Anguera A., Alcaraz, P., and Hernandez, Reyes N. [SAMe in the management of postconcussional syndrome]. Medicina Clinica (Barc.) 1983;80(4):161-164.
- Muscettola G, Galzenati M, Balbi A. SAMe versus placebo: a double blind comparison in major depressive disorders. Advances in Biochemical Psychopharmacology 1982;32:151-6.
- Capretto C, Cremona C, and Canaparo L. A double-blind controlled study of S-adenosylmethionine (SAMe) v. ibuprofen in gonarthrosis, coxarthrosis and spondylarthrosis. Clin Trials J 1985;22(1):15-24.
- Ancarani E, Biondi B, Bolletta A, et al. Major depression complicating hemodialysis in patients with chronic renal failure: a multicenter, double-blind, controlled clinical trial of S-adenosyl-L-methionine versus placebo. Curr Ther Res 1993;54(6):680-6. DOI
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC